PolyPid Net Income
| PYPD Stock | USD 4.58 0.06 1.33% |
As of the 10th of February, PolyPid holds the Risk Adjusted Performance of 0.0968, semi deviation of 2.15, and Coefficient Of Variation of 893.63. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PolyPid, as well as the relationship between them. Please check PolyPid standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if PolyPid is priced some-what accurately, providing market reflects its current price of 4.58 per share. Given that PolyPid has jensen alpha of 0.2259, we recommend you to check out PolyPid's recent market performance to make sure the company can sustain itself at a future point.
PolyPid's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing PolyPid's valuation are provided below:There are over one hundred nineteen available trending fundamental ratios for PolyPid, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of PolyPid's recent performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Enterprise Value is expected to grow to about 20.4 M, whereas Market Cap is forecasted to decline to about 18.5 M. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -35.6 M | -37.4 M | |
| Net Loss | -26.1 M | -27.4 M | |
| Net Loss | -26.1 M | -27.4 M | |
| Net Loss | (5.64) | (5.93) | |
| Net Income Per E B T | 0.90 | 0.77 |
PolyPid | Net Income | Build AI portfolio with PolyPid Stock |
Analyzing PolyPid's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing PolyPid's current valuation and future prospects.
Latest PolyPid's Net Income Growth Pattern
Below is the plot of the Net Income of PolyPid over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in PolyPid financial statement analysis. It represents the amount of money remaining after all of PolyPid operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is PolyPid's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PolyPid's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (29.02 M) | 10 Years Trend |
|
Net Income |
| Timeline |
PolyPid Net Income Regression Statistics
| Arithmetic Mean | (18,503,329) | |
| Geometric Mean | 11,500,276 | |
| Coefficient Of Variation | (93.95) | |
| Mean Deviation | 15,112,466 | |
| Median | (11,392,000) | |
| Standard Deviation | 17,382,987 | |
| Sample Variance | 302.2T | |
| Range | 60.4M | |
| R-Value | (0.61) | |
| Mean Square Error | 201T | |
| R-Squared | 0.38 | |
| Significance | 0.01 | |
| Slope | (2,111,941) | |
| Total Sum of Squares | 4834.7T |
PolyPid Net Income History
Other Fundumenentals of PolyPid
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
PolyPid Net Income component correlations
PolyPid Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for PolyPid is extremely important. It helps to project a fair market value of PolyPid Stock properly, considering its historical fundamentals such as Net Income. Since PolyPid's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PolyPid's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PolyPid's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could PolyPid diversify its offerings? Factors like these will boost the valuation of PolyPid. Anticipated expansion of PolyPid directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PolyPid data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between PolyPid's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PolyPid should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, PolyPid's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
PolyPid 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PolyPid's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PolyPid.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in PolyPid on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding PolyPid or generate 0.0% return on investment in PolyPid over 90 days. PolyPid is related to or competes with Annovis Bio, Reviva Pharmaceuticals, Bioatla, Evaxion Biotech, Celularity, MAIA Biotechnology, and Veru. PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid... More
PolyPid Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PolyPid's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PolyPid upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.54 | |||
| Information Ratio | 0.0756 | |||
| Maximum Drawdown | 14.82 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 4.79 |
PolyPid Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PolyPid's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PolyPid's standard deviation. In reality, there are many statistical measures that can use PolyPid historical prices to predict the future PolyPid's volatility.| Risk Adjusted Performance | 0.0968 | |||
| Jensen Alpha | 0.2259 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0808 | |||
| Treynor Ratio | 0.3837 |
PolyPid February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0968 | |||
| Market Risk Adjusted Performance | 0.3937 | |||
| Mean Deviation | 1.99 | |||
| Semi Deviation | 2.15 | |||
| Downside Deviation | 2.54 | |||
| Coefficient Of Variation | 893.63 | |||
| Standard Deviation | 2.71 | |||
| Variance | 7.35 | |||
| Information Ratio | 0.0756 | |||
| Jensen Alpha | 0.2259 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0808 | |||
| Treynor Ratio | 0.3837 | |||
| Maximum Drawdown | 14.82 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 4.79 | |||
| Downside Variance | 6.44 | |||
| Semi Variance | 4.61 | |||
| Expected Short fall | (2.28) | |||
| Skewness | 0.1687 | |||
| Kurtosis | 0.8121 |
PolyPid Backtested Returns
PolyPid appears to be somewhat reliable, given 3 months investment horizon. PolyPid maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for PolyPid, which you can use to evaluate the volatility of the company. Please evaluate PolyPid's Semi Deviation of 2.15, risk adjusted performance of 0.0968, and Coefficient Of Variation of 893.63 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, PolyPid holds a performance score of 10. The company holds a Beta of 0.76, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PolyPid's returns are expected to increase less than the market. However, during the bear market, the loss of holding PolyPid is expected to be smaller as well. Please check PolyPid's maximum drawdown, as well as the relationship between the expected short fall and rate of daily change , to make a quick decision on whether PolyPid's historical price patterns will revert.
Auto-correlation | 0.27 |
Poor predictability
PolyPid has poor predictability. Overlapping area represents the amount of predictability between PolyPid time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PolyPid price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current PolyPid price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.27 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
PolyPid Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, PolyPid reported net income of (29.02 Million). This is 108.5% lower than that of the Biotechnology sector and 141.43% lower than that of the Health Care industry. The net income for all United States stocks is 105.08% higher than that of the company.
PolyPid Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PolyPid's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PolyPid could also be used in its relative valuation, which is a method of valuing PolyPid by comparing valuation metrics of similar companies.PolyPid is currently under evaluation in net income category among its peers.
PolyPid ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, PolyPid's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to PolyPid's managers, analysts, and investors.Environmental | Governance | Social |
PolyPid Institutional Holders
Institutional Holdings refers to the ownership stake in PolyPid that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of PolyPid's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing PolyPid's value.| Shares | Northwestern Mutual Wealth Management Co | 2025-06-30 | 4 K | Advisor Group Holdings, Inc. | 2025-06-30 | 467 | Sbi Securities Co Ltd | 2025-06-30 | 1.0 | Td Waterhouse Canada Inc | 2025-03-31 | 0.0 | Yelin Lapidot Holdings Management Ltd | 2025-06-30 | 0.0 | Ubs Group Ag | 2025-03-31 | 0.0 | Stonepine Capital Management Llc | 2025-06-30 | 0.0 | Aigh Capital Management, Llc | 2025-06-30 | 1.2 M | Rosalind Advisors, Inc. | 2025-06-30 | 975.5 K | Dafna Capital Management Llc | 2025-06-30 | 207.9 K | J. Goldman & Co Lp | 2025-06-30 | 199.3 K |
PolyPid Fundamentals
| Return On Equity | -3.91 | ||||
| Return On Asset | -0.88 | ||||
| Current Valuation | 60.4 M | ||||
| Shares Outstanding | 16.63 M | ||||
| Shares Owned By Insiders | 15.71 % | ||||
| Shares Owned By Institutions | 40.77 % | ||||
| Number Of Shares Shorted | 19.28 K | ||||
| Price To Book | 4.87 X | ||||
| EBITDA | (26.41 M) | ||||
| Net Income | (29.02 M) | ||||
| Cash And Equivalents | 23.78 M | ||||
| Cash Per Share | 1.22 X | ||||
| Total Debt | 9.62 M | ||||
| Debt To Equity | 0.47 % | ||||
| Current Ratio | 2.87 X | ||||
| Book Value Per Share | 0.92 X | ||||
| Cash Flow From Operations | (21.96 M) | ||||
| Short Ratio | 0.25 X | ||||
| Earnings Per Share | (2.81) X | ||||
| Target Price | 12.25 | ||||
| Number Of Employees | 57 | ||||
| Beta | 1.49 | ||||
| Market Capitalization | 75.19 M | ||||
| Total Asset | 25.22 M | ||||
| Retained Earnings | (267.33 M) | ||||
| Working Capital | 3.89 M | ||||
| Net Asset | 25.22 M |
About PolyPid Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PolyPid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PolyPid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PolyPid based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:Check out For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Biotechnology sector continue expanding? Could PolyPid diversify its offerings? Factors like these will boost the valuation of PolyPid. Anticipated expansion of PolyPid directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PolyPid data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between PolyPid's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PolyPid should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, PolyPid's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.